NCT01507467View on ClinicalTrials.gov

IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck

PHASE3TerminatedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2016

Conditions
Head and Neck Carcinoma
Interventions
RADIATION

Accl. RT

Accelerated Radiotherapy: Radiotherapy 66-70 Gy, 2Gy/fx, 6fx/week

RADIATION

Accl. radiotherapy + Nimorazole

Radiation: Radiotherapy 66-70 Gy, 2Gy/fx, 6fx/week plus Nimorazole (tablets or powder) 1.2 g/m2 body surface in connection with the first daily radiation treatments

Trial Locations (6)

13419

Radiation Oncology Center, Tallinn

Unknown

Radiation Oncology Department, National Cancer Institute, Cairo

Nuclear Medicine, Oncology & Radiotherapy Institute, Radiation Oncology Department G-8/3, Islamabad

Karachi Institute of Radiotherapy and Nuclear Medicine, Karachi

Institute of Radiotherapy and Nuclear Medicine (IRNUM) Hospital Peshawar, Peshawar

Institute of Oncology Department of Radiation Oncology, Ljubljana

Sponsors
All Listed Sponsors
collaborator

International Atomic Energy Agency

OTHER_GOV

collaborator

Danish Center for Interventional Research in Radiation Oncology (CIRRO)

OTHER

lead

Danish Head and Neck Cancer Group

NETWORK